Wellness Reimagined: Mike Litvinenko Of Eximion On 5 Things That Should Be Done To Improve and…

Authority Magazine: Wellness Reimagined: Mike Litvinenko Of Eximion On 5 Things That Should Be Done To Improve and Reform The Health & Wellness Industry -- Listen Share The discomfort of change is always less than the cost of staying the same. The discomfort of change is always less than the cost of staying the same. As a part of this series, we had the distinct pleasure of interviewing Mike Litvinenko. Mike Litvinenko is the CEO and Co-Founder of Eximion, a vertical AI for healthcare company that measures and improves clinical decision behavior through competitive clinical simulations, with a flagship focus on rare disease and diagnostic uncertainty.

As a rare disease patient who spent years traveling the world in search of a correct diagnosis, Mike experienced firsthand how the healthcare system fails patients when it matters most. Today, Eximion operates across 5 countries and 7 medical specialties, partnering with leading pharmaceutical companies to transform how physicians learn, compete, and improve. Thank you so much for doing this interview. Our readers would love to learn more about you and your personal background. Can you please share your personal backstory? What has brought you to this point in your life? I’m a rare disease patient.

That’s not just context for what I do — it’s the entire reason I do it. For years, I traveled from country to country looking for someone who could figure out what was wrong with me. I spent a lot of money. I saw a lot of doctors. And I could not find a single one who could connect the dots and give me a correct diagnosis. That experience broke something in me, but it also built something. I started thinking: if I can’t find these brilliant diagnosticians through the normal system, what if we built a way to surface them?

What if we created competitions — like a Medical Olympics — where physicians have to prove they can actually solve complex cases? That idea became Eximion. Along the way, AI entered the picture. While I was deep in research about my own conditions, AI tools started helping me find answers that human doctors had missed. So the mission evolved. Now it’s not just about finding the best doctors — it’s about helping all physicians develop the skills to work with AI and become better diagnosticians. What is your “why” behind the work that you do? What fuels you? Patients like me. That’s it.

The average rare disease patient waits 5 to 7 years for a correct diagnosis. Some wait longer. Some never get one. Every one of those years is filled with wrong treatments, wrong medications, emotional exhaustion, financial drain, and the feeling that nobody in the system actually cares enough to figure it out. I got lucky. I eventually found my path. But most people don’t. And the thing that keeps me going is knowing that if we can improve how physicians think, how they use AI, and how they approach complex cases, we can cut that 5-to-7-year wait down to months or even weeks. That’s not abstract for me.

That’s someone’s life. What are some of the most interesting or exciting new projects you are working on now? The most exciting thing we’re building right now is a framework for evaluating physicians’ AI competency through competitions. We’re creating a layer that measures not just whether a doctor can diagnose a condition, but how well they can work with AI tools in a clinical scenario. Can they critically evaluate what the AI suggests? Can they catch its mistakes? Do they know when to trust it and when to override it? Nobody is measuring this yet. Medical education is still built around the old model — memorize, recall, repeat.

Article truncated for readability. Read the full piece →

The article discusses significant changes in the health and wellness industry that could influence brand positioning, making it impactful and relevant, while the integration of AI tools is becoming more common, slightly reducing its novelty.